{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:23:53Z","timestamp":1791624233270,"version":"4.3.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"DOI":"10.7759\/cureus.71775","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T10:16:27Z","timestamp":1729246587000},"source":"Crossref","is-referenced-by-count":2,"title":["Association of Anabolic Steroid Use With Hypertension and Cardiomyopathy: A Case Study"],"prefix":"10.7759","author":[{"given":"Sarvesh","family":"Neupane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falguni","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Anabolic steroids and other appearance and performance enhancing drugs (APEDs). (2024). Accessed. March 1, 2024: https:\/\/nida.nih.gov\/research-topics\/anabolic-steroids."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01882","article-title":"Diagnosis and management of anabolic androgenic steroid use","volume":"104","author":"Anawalt BD","year":"2019","unstructured":"Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019, 104:2490-500. 10.1210\/jc.2018-01882","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9333","article-title":"Anabolic steroids and cardiovascular outcomes: the controversy","volume":"12","author":"Perry JC","year":"2020","unstructured":"Perry JC, Schuetz TM, Memon MD, Faiz S, Cancarevic I. Anabolic steroids and cardiovascular outcomes: the controversy. Cureus. 2020, 12:e9333. 10.7759\/cureus.9333","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000407","article-title":"Anabolic-androgenic steroids and cardiovascular risk","volume":"132","author":"Liu JD","year":"2019","unstructured":"Liu JD, Wu YQ. Anabolic-androgenic steroids and cardiovascular risk. Chin Med J (Engl). 2019, 132:2229-36. 10.1097\/CM9.0000000000000407","journal-title":"Chin Med J (Engl)"},{"key":"ref5","article-title":"Congestive heart failure","author":"Malik A","year":"2023","unstructured":"Malik A, Brito D, Vaqar S, Chhabra L. Congestive heart failure. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.91.11.2742","article-title":"Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses","volume":"91","author":"Ajayi AA","year":"1995","unstructured":"Ajayi AA, Mathur R, Halushka PV. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 1995, 91:2742-7. 10.1161\/01.cir.91.11.2742","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2217\/clp.10.11","article-title":"Thromboxane and the thromboxane receptor in cardiovascular disease","volume":"5","author":"Smyth EM","year":"2010","unstructured":"Smyth EM. Thromboxane and the thromboxane receptor in cardiovascular disease. Clin Lipidol. 2010, 5:209-19. 10.2217\/clp.10.11","journal-title":"Clin Lipidol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1991.00400100013003","article-title":"Atherogenic effects of anabolic steroids on serum lipid levels. A literature review","volume":"151","author":"Glazer G","year":"1991","unstructured":"Glazer G. Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Arch Intern Med. 1991, 151:1925-33.","journal-title":"Arch Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1059473","article-title":"Anabolic-androgenic steroids: how do they work and what are the risks?","volume":"13","author":"Bond P","year":"2022","unstructured":"Bond P, Smit DL, de Ronde W. Anabolic-androgenic steroids: how do they work and what are the risks?. Front Endocrinol (Lausanne). 2022, 13:1059473. 10.3389\/fendo.2022.1059473","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1214374","article-title":"Anabolic androgenic steroids and cardiomyopathy: an update","volume":"10","author":"Fadah K","year":"2023","unstructured":"Fadah K, Gopi G, Lingireddy A, Blumer V, Dewald T, Mentz RJ. Anabolic androgenic steroids and cardiomyopathy: an update. Front Cardiovasc Med. 2023, 10:1214374. 10.3389\/fcvm.2023.1214374","journal-title":"Front Cardiovasc Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.98.3.256","article-title":"Androgen receptors mediate hypertrophy in cardiac myocytes","volume":"98","author":"Marsh JD","year":"1998","unstructured":"Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation. 1998, 98:256-61. 10.1161\/01.cir.98.3.256","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.015719","article-title":"Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?","volume":"90","author":"Urhausen A","year":"2004","unstructured":"Urhausen A, Albers T, Kindermann W. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart. 2004, 90:496-501. 10.1136\/hrt.2003.015719","journal-title":"Heart"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/233411-association-of-anabolic-steroid-use-with-hypertension-and-cardiomyopathy-a-case-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T10:16:30Z","timestamp":1729246590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/233411-association-of-anabolic-steroid-use-with-hypertension-and-cardiomyopathy-a-case-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.71775","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}